NSE · AI Signal & Stock Analysis · Neutral
As of Sep 23 2026, 6:51 PM, AkshayaAI's signal for RPGLIFE is Neutral → (moderate move); technical trend raise-2026-09-04; trading at ₹2,721.60 (+2.61% today); neutral (RSI 56).
Data as of Sep 23 2026, 6:51 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Moderate move |
|---|---|
| Technical trend | RAISE-2026-09-04 |
| Price | ₹2,721.60 |
| Change today | +2.61% |
| RSI (14) | 55.80 |
| Relative volume | 0.87 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹5,004 Cr |
| P/E | 41.88 |
| Cap category | Mid Cap |
| 52-week high | -9.8% away |
| 52-week low | +57.6% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 23 2026, 6:51 PM, AkshayaAI's signal for RPGLIFE (RPG Life Sciences Limited) is Neutral with a moderate move, and its technical trend is raise-2026-09-04. The composite score and full factor breakdown are available to signed-in members.
RPGLIFE's RSI is neutral (RSI 56). A reading above 70 is typically overbought and below 30 oversold.
RPGLIFE is trading about 10% below its 52-week high and 58% above its 52-week low as of Sep 23 2026, 6:51 PM.
RPGLIFE's market capitalisation is ₹5,004 Cr as of Sep 23 2026, 6:51 PM.
RPGLIFE is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for RPGLIFE — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 23 2026, 6:51 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.